PYXS
Pyxis Oncology Inc
NASDAQ: PYXS · HEALTHCARE · BIOTECHNOLOGY
$1.70
+2.41% today
Updated 2026-04-30
Market cap
$106.81M
P/E ratio
—
P/S ratio
7.71x
EPS (TTM)
$-1.28
Dividend yield
—
52W range
$1 – $6
Volume
0.4M
Pyxis Oncology Inc (PYXS) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Operating cash flow | $-2.24M | $-10.08M | $-35.33M | $-89.33M | $-70.71M | $-57.67M | $-63.50M |
| Capital expenditures | $1.48M | $1.48M | $540000.00 | $6.40M | $6.73M | $237000.00 | $9000.00 |
| Depreciation | — | — | — | — | — | — | — |
| Stock-based comp | $28000.00 | $44000.00 | $6.44M | $15.76M | $16.95M | $12.95M | $11.80M |
| Free cash flow | $-3.72M | $-11.57M | $-35.87M | $-95.73M | $-77.44M | $-57.91M | $-63.51M |
| Investing cash flow | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — |
| Net change in cash | — | — | $268.13M | $-95.55M | — | — | — |